Literature DB >> 33520856

Polydatin-loaded chitosan nanoparticles ameliorates early diabetic nephropathy by attenuating oxidative stress and inflammatory responses in streptozotocin-induced diabetic rat.

Abeer M Abd El-Hameed1.   

Abstract

In various developed countries, diabetic nephropathy (DN) is the principal cause of end-stage kidney disease and a main reason of injury and mortality in individuals with renal morbidity worldwide. Polydatin (POL) has been evaluated as a potential antioxidant, anti-inflammatory and a nephroprotective agent. In spite of this, the possible benefits and protective effects of POL on early diabetic nephropathy are not quite clarified. For the effective clearance from the body besides safe drug delivery, biodegradable nanoparticles have interesting attraction. This work was designed to evaluate the positive effect and possible mechanisms of Polydatin-loaded Chitosan-Nanoparticles (POL-NPs) on early DN in streptozotocin-induced diabetic rats. Followed the induction of diabetes, rats classified into four groups, diabetic control and diabetic rats treated daily and orally with; POL, Polydatin-loaded chitosan-Nanoparticles (POL-NPs), plus normal control rats. Our findings showed that diabetic group presented a significant high level of the blood glucose, blood glycosylated hemoglobin (HbA1c), serum insulin, renal function related parameters, renal Advanced glycation-end products (AGEs) and lipid peroxidation level compared to normal control rats, while serum albumin level and the activities of renal antioxidant enzymes were significantly decreased. Moreover, in the kidney of diabetic rat mRNA expression of nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (Cox-2) were up-regulated. Besides, increase in serum levels of pro-inflammatory cytokines (TNF-α, IL-6 and IL-18) and decrease in anti-inflammatory cytokine (IL-10). POL and POL-NPs supplementation were significantly attenuate the above-mention results and returned the normal equilibrium between pro- and anti-inflammatory cytokines. In conclusion, POL and POL-NPs have antidiabetic effect, suppresses oxidative stress and mitigates renal inflammation through inhibition of NF-κB in diabetic kidney in early progressive DN. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Advanced glycation-end products; Diabetic nephropathy; Hypoglycemia; Inflammatory cytokines; NF-κB; Oxidative stress; Polydatin-loaded-chitosan nanoparticles

Year:  2020        PMID: 33520856      PMCID: PMC7843669          DOI: 10.1007/s40200-020-00699-7

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  40 in total

1.  Differentially expressed protein profile of renal tubule cell stimulated by elevated uric acid using SILAC coupled to LC-MS.

Authors:  Hong Quan; Xue Peng; Shuwen Liu; Fu Bo; Lv Yang; Zhiyong Huang; Haixia Li; Xiangmei Chen; Wu Di
Journal:  Cell Physiol Biochem       Date:  2011-02-11

2.  Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats.

Authors:  Ayman M Mahmoud; Mohamed B Ashour; Adel Abdel-Moneim; Osama M Ahmed
Journal:  J Diabetes Complications       Date:  2012-07-17       Impact factor: 2.852

3.  Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPARγ, proinflammatory cytokines and oxidative stress.

Authors:  Ahmed A Hosni; A Adel Abdel-Moneim; Eman S Abdel-Reheim; Samah M Mohamed; Hamdi Helmy
Journal:  Biomed Pharmacother       Date:  2017-01-13       Impact factor: 6.529

4.  Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes.

Authors:  F Nicoletti; I Conget; R Di Marco; A M Speciale; R Morìnigo; K Bendtzen; R Gomis
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

5.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

Authors:  Katalin Susztak; Amanda C Raff; Mario Schiffer; Erwin P Böttinger
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

6.  Interleukin-6 gene polymorphism and insulin sensitivity.

Authors:  J M Fernández-Real; M Broch; J Vendrell; C Gutiérrez; R Casamitjana; M Pugeat; C Richart; W Ricart
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

Review 7.  Polydatin: a review of pharmacology and pharmacokinetics.

Authors:  Qiao-Hui Du; Cheng Peng; Hong Zhang
Journal:  Pharm Biol       Date:  2013-07-18       Impact factor: 3.503

8.  Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.

Authors:  P Akarasereenont; Y S Bakhle; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

Review 9.  Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.

Authors:  Ting-Ting Wan; Xiu-Fen Li; Yan-Ming Sun; Yan-Bo Li; Ying Su
Journal:  Biomed Pharmacother       Date:  2015-08-13       Impact factor: 6.529

10.  Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice.

Authors:  Hong Zhang; Cheng-Hao Yu; Yi-Ping Jiang; Cheng Peng; Kun He; Jian-Yuan Tang; Hai-Liang Xin
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

View more
  5 in total

1.  Curcumin, Polydatin and Quercetin Synergistic Activity Protects from High-Glucose-Induced Inflammation and Oxidative Stress.

Authors:  Giulia Matacchione; Debora Valli; Andrea Silvestrini; Angelica Giuliani; Jacopo Sabbatinelli; Chiara Giordani; Sofia Coppari; Maria Rita Rippo; Maria Cristina Albertini; Fabiola Olivieri
Journal:  Antioxidants (Basel)       Date:  2022-05-24

2.  Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting Ferroptosis.

Authors:  Lu Zhou; Peng Yu; Ting-Ting Wang; Yi-Wei Du; Yang Chen; Zhen Li; Man-Lin He; Lan Feng; Hui-Rong Li; Xiao Han; Heng Ma; Hong-Bao Liu
Journal:  Oxid Med Cell Longev       Date:  2022-01-15       Impact factor: 6.543

Review 3.  Polyphenols and Their Metabolites in Renal Diseases: An Overview.

Authors:  Íris Guerreiro; Cíntia Ferreira-Pêgo; Diogo Carregosa; Cláudia N Santos; Regina Menezes; Ana S Fernandes; João G Costa
Journal:  Foods       Date:  2022-04-06

Review 4.  Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy.

Authors:  Chunkang Liu; Kunzhe Wu; Huan Gao; Jianyang Li; Xiaohua Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-31       Impact factor: 3.249

Review 5.  Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits.

Authors:  Ahmad Karami; Sajad Fakhri; Leila Kooshki; Haroon Khan
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.